=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-05-27
10b5-1 Pre-arranged Plan: No
--- Issuer ---
Name: Moderna, Inc. (MRNA)
CIK: 0001682852
--- Reporting Owner ---
Name: Hoge Stephen
CIK: 0001760669
Role: Officer (President)
--- Non-Derivative Transactions ---
[Transaction #1]
Security: Common Stock
Date: 2026-05-27 | Code: M (Exercise of derivative)
Shares: +1,437
Shares Owned After: 1,479,434 | Ownership: D (Direct)
Footnotes:
[F1] Restricted stock units convert into common stock on a one-for-one basis.
[F1] Restricted stock units convert into common stock on a one-for-one basis.
[Transaction #2]
Security: Common Stock
Date: 2026-05-27 | Code: F (Payment of exercise/tax)
Shares: -695 | Price: $47.03
Total Value: $32,685.85
Shares Owned After: 1,478,739 | Ownership: D (Direct)
Footnotes:
[F2] Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units.
[Transaction #3]
Security: Common Stock
Date: 2026-05-28 | Code: M (Exercise of derivative)
Shares: +610
Shares Owned After: 1,479,349 | Ownership: D (Direct)
Footnotes:
[F1] Restricted stock units convert into common stock on a one-for-one basis.
[F1] Restricted stock units convert into common stock on a one-for-one basis.
[Transaction #4]
Security: Common Stock
Date: 2026-05-28 | Code: F (Payment of exercise/tax)
Shares: -295 | Price: $47.61
Total Value: $14,044.95
Shares Owned After: 1,479,054 | Ownership: D (Direct)
Footnotes:
[F2] Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units.
--- Derivative Transactions ---
[Transaction #1]
Security: Restricted Stock Units
Date: 2026-05-27 | Code: M (Exercise of derivative)
Shares: -1,437 | Price: $0.00
Shares Owned After: 10,058 | Ownership: D (Direct)
Footnotes:
[F1] Restricted stock units convert into common stock on a one-for-one basis.
[F1] Restricted stock units convert into common stock on a one-for-one basis.
[F4] 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
[F4] 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
[Transaction #2]
Security: Restricted Stock Units
Date: 2026-05-28 | Code: M (Exercise of derivative)
Shares: -610 | Price: $0.00
Shares Owned After: 1,832 | Ownership: D (Direct)
Footnotes:
[F1] Restricted stock units convert into common stock on a one-for-one basis.
[F1] Restricted stock units convert into common stock on a one-for-one basis.
[F5] 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
[F5] 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
--- Holdings ---
[Holding #1]
Security: Common Stock
Ownership: I (Indirect)
[Holding #2]
Security: Common Stock
Ownership: I (Indirect)
Footnotes:
[F3] These shares are owned directly by a trust for the benefit of Dr. Hoge's spouse and children, of which his spouse is a trustee. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose.
--- Footnotes (Complete Index) ---
F1: Restricted stock units convert into common stock on a one-for-one basis.
F2: Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units.
F3: These shares are owned directly by a trust for the benefit of Dr. Hoge's spouse and children, of which his spouse is a trustee. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose.
F4: 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
F5: 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
--- Signature ---
/s/ /s/ James Dillon, as Attorney-in-Fact (2026-05-29)
